The direct and indirect roles of HBV in liver cancer: prospective markers for HCC screening and potential therapeutic targets.
about
Significance of hepatitis virus infection in the oncogenic initiation of hepatocellular carcinomaDeficient mismatch repair: Read all about it (Review)Nested case-control study: hepatocellular carcinoma risk after hepatitis B surface antigen seroclearance.The Role of cccDNA in HBV Maintenance.The Dual Role of an ESCRT-0 Component HGS in HBV Transcription and Naked Capsid Secretion.Oncogenic Wnt3a expression as an estimable prognostic marker for hepatocellular carcinoma.Dual oncogenic and tumor suppressor roles of the promyelocytic leukemia gene in hepatocarcinogenesis associated with hepatitis B virus surface antigen.Multi-omics analyses reveal metabolic alterations regulated by hepatitis B virus core protein in hepatocellular carcinoma cells.Immunotherapy against cancer-related viruses.Redox proteomics screening cellular factors associated with oxidative stress in hepatocarcinogenesis.Hepatitis B core antigen upregulates B7-H1 on dendritic cells by activating the AKT/ERK/P38 pathway: a possible mechanism of hepatitis B virus persistence.Viral hepatitis and liver cancer.Hepatitis B Virus Activates Signal Transducer and Activator of Transcription 3 Supporting Hepatocyte Survival and Virus Replication.Associations between single nucleotide polymorphisms in RYBP and the prognosis of hepatocellular carcinoma in a Chinese population.Long noncoding RNA HULC modulates the phosphorylation of YB-1 through serving as a scaffold of extracellular signal-regulated kinase and YB-1 to enhance hepatocarcinogenesis.MiR-19a, miR-122 and miR-223 are differentially regulated by hepatitis B virus X protein and involve in cell proliferation in hepatoma cells.Canonical NF-κB signaling in hepatocytes acts as a tumor-suppressor in hepatitis B virus surface antigen-driven hepatocellular carcinoma by controlling the unfolded protein response.Identification of differentially expressed inflammatory factors in Wilms tumors and their association with patient outcomes.Systematic analysis of molecular mechanisms for HCC metastasis via text mining approach.Guidelines for the use of flow cytometry and cell sorting in immunological studies.Viruses and disease: emerging concepts for prevention, diagnosis and treatment.Single nucleotide polymorphisms in MLH1 predict poor prognosis of hepatocellular carcinoma in a Chinese population.Diverse modes of clonal evolution in HBV-related hepatocellular carcinoma revealed by single-cell genome sequencing.Ribavirin augments doxorubicin's efficacy in human hepatocellular carcinoma through inhibiting doxorubicin-induced eIF4E activation.Capable Infection of Hepatitis B Virus in Diffuse Large B-cell Lymphoma.Comparison of anti-HBV regimen with or without adefovir on hepatocellular carcinoma development of Chronic hepatitis B patients with compensated cirrhosis: a retrospective cohort study.VEGF Upregulation in Viral Infections and Its Possible Therapeutic Implications.Hepatitis B virus promotes β-catenin-signalling and disassembly of adherens junctions in a Src kinase dependent fashionTenofovir disoproxil fumarate reduce incidence of HCC development in CHB-patients with compensated cirrhosisEvaluating intrinsic and non-intrinsic cancer risk factors
P2860
Q26773251-C9BDE623-CD8E-4DC1-96C3-615465B44FCEQ26796491-289F3715-B431-4E18-9854-AB903A081A74Q30152115-EA1D1913-D8CE-4108-9A03-B8A0B3475DB9Q32182914-5AEBA24E-D293-4DE9-815B-6FBB315A2BB8Q35797289-68F78447-5ED8-4A15-A32E-D8B18A80F64CQ36747844-CD61476B-DD3F-4359-B1CB-B8125247BEAAQ37317562-CCD820F9-B8C9-442E-A7F4-C21C255910C0Q37598554-E2C34532-3CAA-45CE-9B82-342F6B8C927DQ38778924-7B6A57B2-B9CD-40BE-BCD4-9E9B7DF47B28Q38986144-61D916F2-3609-457F-A949-0A0A2EA76927Q39401740-A9F399BC-997A-42F4-8376-7F63E782BBB1Q40046596-46CA0002-7FBD-4442-A889-12C4F4FECF44Q40051813-02216AFF-134E-46BD-9C39-CC304F9CB126Q40261995-70F2B972-23C2-4B8F-9662-1EE802138167Q40405868-AEC04DB7-6538-46B1-9A12-4E7E93160085Q40767105-F414509B-38AC-4595-9177-D8A5DE64BC6FQ40785717-9C8671E2-234A-4C65-A40A-A7DD6C0345F3Q40979439-92153A19-776B-4FFE-986E-B21E77F1859EQ41891731-343164DA-C47F-4D16-9C30-163A212B3F4BQ41918189-35AB6456-97A3-48A2-9CF2-474BB1C37B35Q44094328-5CE1AFD4-AAB9-4877-9100-77921FD91157Q47141489-004DBBFD-370F-4B84-9256-7BCF7262B990Q47554590-A0EB6518-5758-41D2-9591-1434119FE28FQ47720139-541C9E49-C621-451D-A934-462E6ABC75C6Q55044828-7B361F70-50E9-41FC-A3E0-485502B76CAAQ55279434-AEB61EF6-F00D-4FF2-9656-F9881652F8BEQ55618701-AEDDB3D1-7EC2-4B6D-93DC-B00BA47CD3C4Q58553009-6BC01F38-A3D7-4514-8585-23EF07EE33A6Q58696387-F7A02FA7-DCEA-4CE4-BE2D-DCBC72691E59Q58699695-BB18DDFC-7799-4180-9CC8-EA046A9BB0C4
P2860
The direct and indirect roles of HBV in liver cancer: prospective markers for HCC screening and potential therapeutic targets.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
The direct and indirect roles ...... potential therapeutic targets.
@en
type
label
The direct and indirect roles ...... potential therapeutic targets.
@en
prefLabel
The direct and indirect roles ...... potential therapeutic targets.
@en
P2860
P356
P1476
The direct and indirect roles ...... potential therapeutic targets
@en
P2093
Mathias Heikenwalder
Tracy O'Connor
P2860
P304
P356
10.1002/PATH.4434
P407
P577
2015-01-01T00:00:00Z